Year |
Citation |
Score |
2020 |
Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, Brooks DJ, Darcourt J, Dickson JC, Douglas D, Drzezga A, Dubroff J, Ekmekcioglu O, Garibotto V, Herscovitch P, ... ... Zubal G, et al. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32388612 DOI: 10.1007/S00259-020-04817-8 |
0.308 |
|
2018 |
Kuo PH, Eshghi N, Tinaz S, Blumenfeld H, Louis ED, Zubal G. Optimization of Parameters for Quantitative Analysis of I-ioflupane SPECT Images for Monitoring of Progression of Parkinson's Disease. Journal of Nuclear Medicine Technology. PMID 30139881 DOI: 10.2967/Jnmt.118.213181 |
0.365 |
|
2017 |
Tinaz S, Chow C, Kuo PH, Krupinski EA, Blumenfeld H, Louis ED, Zubal G. Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease. Clinical Nuclear Medicine. PMID 29112012 DOI: 10.1097/Rlu.0000000000001885 |
0.317 |
|
2013 |
Kuo PH, Avery R, Krupinski E, Lei H, Bauer A, Sherman S, McMillan N, Seibyl J, Zubal G. Receiver-operating-characteristic analysis of an automated program for analyzing striatal uptake of 123I-ioflupane SPECT images: calibration using visual reads. Journal of Nuclear Medicine Technology. 41: 26-31. PMID 23401604 DOI: 10.2967/Jnmt.112.114827 |
0.39 |
|
2013 |
Seibyl J, Wisniewski G, Ferraiolo D, Marek K, Zubal G. Quantitative evaluation of anthropomorphic brain phantoms for standardization of amyloid PET SUVrs in alzheimer's Multicenter Therapeutic Trials Alzheimers & Dementia. 9: 594. DOI: 10.1016/J.Jalz.2013.05.1185 |
0.396 |
|
2012 |
Wyman B, Peng Y, Lobello K, Zubal G, Ryan M, Marek K, Seibyl J, Slomkowski M. Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.098 |
0.35 |
|
2011 |
Zubal G, Barret O, Wisniewski G, Barthel H, Pessel M, Reininger C, Osama S, Seibyl J. An automated, operator-independent method for evaluating various brain areas of florbetaben PET scans to compare regional normal versus diseased beta-amyloid burdens Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.997 |
0.411 |
|
2011 |
Barthel H, Butzke D, Diemling M, Senda M, Sattler B, Zubal G, Seibyl J, Gertz H, Pessel M, Reininger C, Osama S. Automated regional and voxel-wise quantification of florbetaben beta-amyloid brain PET Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.078 |
0.407 |
|
2010 |
Seibyl J, Barret O, Zubal G, Hiemeyer F, Reininger C, Barthel H, Batis J, Wisniewski G, Sabri O. Objective SUVr Determination using MRI Segmentation Maps in Florbetaben Beta-amyloid Brain PET Improves Discrimination of Alzheimer's and Controls Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.141 |
0.395 |
|
2010 |
Hiemeyer F, Seibyl JP, Kunz M, Barret O, Zubal G, Barthel H, Reininger C, Sabri O. A Model-Based Approach to Improve Intra-Individual Comparison of Clustered Beta-Amyloid Brain PET Imaging Data: Accounting for Overlapping Imaging Time Windows Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.134 |
0.436 |
|
2010 |
Zubal G, Wisniewski G, Barret O, Batis J, Marek K, Seibyl JP. Image Quantification Methods of PET Beta-Amyloid Scans Applicable to Clinical Trials Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.067 |
0.429 |
|
2009 |
Seibyl JP, Zubal G, Tamagnan G, Marek K. Multicenter quantitative amyloid PET imaging in phase III alzheimer therapeutic trials: Strategies for achieving good imaging practices in the support of drug development Alzheimers & Dementia. 5: 265. DOI: 10.1016/J.Jalz.2009.05.099 |
0.401 |
|
2008 |
Seibyl J, Marek K, Jennings D, Tamagnan G, Zubal G. IC-P3-215: Automated image processing algorithms for evaluating novel 123-Iodine-labeled beta-amyloid imaging agents MNI-187 and MNI-308 in Alzheimer's patients Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.160 |
0.377 |
|
1995 |
Abi-Dargham A, Krystal J, Laruelle M, D'Souza D, Zoghbi S, Brenner L, Gil R, Sernyak M, Baldwin R, Zubal G, Hoffer P, Charney D, Innis R. Spect imaging of the benzodiazepine receptor in schizophrenics and healthy subjects Schizophrenia Research. 15: 75. DOI: 10.1016/0920-9964(95)95236-3 |
0.325 |
|
1991 |
Innis R, Zoghbi S, Johnson E, Woods S, Al-Tikriti M, Baldwin R, Seibyl J, Malison R, Zubal G, Charney D, Heninger G, Hoffer P. SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154 European Journal of Pharmacology. 193: 249-252. PMID 1646734 DOI: 10.1016/0014-2999(91)90043-P |
0.338 |
|
Show low-probability matches. |